OSE Immunotherapeutics SA (EPA:OSE)
4.300
-0.088 (-2.01%)
At close: Feb 20, 2026
Revenue by Segment
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.